 |
Beta-Herpesviruses in Febrile Children With Cancer CME DisclosuresRelease Date: March 27, 2008; Valid for credit through March 27, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
- Beta-Herpesviruses in Febrile Children With Cancer
Stephanie Yee-Guardino, DO
Kate Gowans, MD
Belinda Yen-Lieberman, PhD
Pamela Berk, BS
Debra Kohn, BS, MT
Fu-Zhang Wang, PhD
Lara Danziger-Isakov, MD, MPH
Camille Sabella, MD
Sarah Worley, MS
Philip E. Pellett, PhD
Johanna Goldfarb, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Identify common infections associated with beta-herpesviruses
- Specify beta-herpesviruses isolated from children in the current study
- Describe clinical characteristics of beta-herpesvirus infections in the current
study
- List factors associated with higher rates of infection with human herpesvirus in the current study
Authors and Disclosures Stephanie Yee-Guardino, DO
Disclosure: Stephanie Yee-Guardino, DO, has disclosed no relevant financial relationships. Kate Gowans, MD
Disclosure: Kate Gowans, MD, has disclosed no relevant financial relationships. Belinda Yen-Lieberman, PhD
Disclosure: Belinda Yen-Lieberman, PhD, has disclosed that she has received reagents at no charge from ARTUS Diagnostics. Pamela Berk, BS
Disclosure: Pamela Berk, BS, has disclosed no relevant financial relationships.
Debra Kohn, BS, MT
Disclosure: Debra Kohn, BS, MT, has disclosed no relevant financial relationships. Fu-Zhang Wang, PhD
Disclosure: Fu-Zhang Wang, PhD, has disclosed no relevant financial relationships. Lara Danziger-Isakov, MD, MPH
Disclosure: Lara Danziger-Isakov, MD, MPH, has disclosed no relevant financial
relationships. Camille Sabella, MD
Disclosure: Camille Sabella, MD, has disclosed that she has received grants from Merck, Inc. and Sanofi Pasteur. Sarah Worley, MS
Disclosure: Sarah Worley, MS, has disclosed no relevant financial relationships. Philip E. Pellett, PhD
Disclosure: Philip E.
Pellett, PhD, has disclosed that he has received royalties from Chemicon International. Johanna Goldfarb, MD
Disclosure: Johanna Goldfarb, MD, has disclosed no relevant financial relationships. Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.
D. Peter Drotman, MD
Disclosure: D. Peter Drotman, MD, has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
